International consensus statement on allergy and rhinology: Allergic rhinitis–2023
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Challenges of sarcoidosis and its management
M Drent, ED Crouser, J Grunewald - New England Journal of …, 2021 - Mass Medical Soc
Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …
2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of …
The systemic amyloidoses are a broad spectrum of diseases that result from misfolding of
proteins that aggregate into b-sheet amyloid fibrils. Over 35 amyloidogenic precursor …
proteins that aggregate into b-sheet amyloid fibrils. Over 35 amyloidogenic precursor …
ERS clinical practice guidelines on treatment of sarcoidosis
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
Interleukin 6: at the interface of human health and disease
E Grebenciucova, S VanHaerents - Frontiers in immunology, 2023 - frontiersin.org
Interleukin 6 (IL-6) is a pleiotropic cytokine executing a diverse number of functions, ranging
from its effects on acute phase reactant pathways, B and T lymphocytes, blood brain barrier …
from its effects on acute phase reactant pathways, B and T lymphocytes, blood brain barrier …
Sarcoidosis: a clinical overview from symptoms to diagnosis
P Sève, Y Pacheco, F Durupt, Y Jamilloux… - Cells, 2021 - mdpi.com
Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of
granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any …
granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any …
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …
Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
N Gonzalez Caldito - Frontiers in Immunology, 2023 - frontiersin.org
Tumor necrosis factor-alpha (TNF-α) is a pleiotropic immune cytokine that belongs to the
TNF superfamily of receptor ligands. The cytokine exists as either a transmembrane or a …
TNF superfamily of receptor ligands. The cytokine exists as either a transmembrane or a …
Sarcoidosis: Epidemiology and clinical insights
Sarcoidosis is characterized by noncaseating granulomas which form in almost any part of
the body, primarily in the lungs and/or thoracic lymph nodes. Environmental exposures in …
the body, primarily in the lungs and/or thoracic lymph nodes. Environmental exposures in …
Neurosarcoidosis: pathophysiology, diagnosis, and treatment
Although often regarded as a protean illness with myriad clinical and imaging
manifestations, neurosarcoidosis typically presents as recognizable syndromes that can be …
manifestations, neurosarcoidosis typically presents as recognizable syndromes that can be …